GeneReach Biotechnology Corp. (4171.TWO)
TWD 17.1
(-4.2%)
TWD 17.1
(-4.2%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 40.26 Million TWD | 111.63% |
| 2022 | -346.11 Million TWD | -28.75% |
| 2021 | -268.82 Million TWD | -152.71% |
| 2020 | -106.37 Million TWD | 30.26% |
| 2019 | -152.52 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 80.73 Million TWD | 235.15% |
| 2024 Q1 | 24.09 Million TWD | -40.17% |
| 2023 FY | 40.26 Million TWD | 111.63% |
| 2023 Q1 | -300.08 Million TWD | 37.51% |
| 2023 Q4 | 40.26 Million TWD | 114.84% |
| 2023 Q3 | -271.41 Million TWD | -1104.31% |
| 2023 Q2 | -22.53 Million TWD | 92.49% |
| 2022 Q4 | -480.19 Million TWD | 0.0% |
| 2022 FY | -346.11 Million TWD | -28.75% |
| 2021 FY | -268.82 Million TWD | -152.71% |
| 2020 FY | -106.37 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 115.243% |
| Level Biotechnology Inc. | -453.9 Million TWD | 108.871% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 133.396% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 120.502% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 91.944% |
| GlycoNex Incorporation | -148.56 Million TWD | 127.103% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 70.821% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 115.335% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | -31.683% |
| Visgeneer Inc. | 31.28 Million TWD | -28.711% |
| Mycenax Biotech Inc. | 207 Million TWD | 80.549% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 105.916% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 129.993% |
| Neith Corporation | -150.31 Million TWD | 126.788% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 93.522% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 169.836% |
| Enimmune corporation | -314.15 Million TWD | 112.817% |
| TaiRx, Inc. | -147.86 Million TWD | 127.231% |
| EirGenix Inc. | -4.58 Billion TWD | 100.878% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 147.504% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 66.687% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 101.251% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 112.685% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 303.23% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | -26.587% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 20.666% |
| RBC Bioscience Corporation | 422.18 Million TWD | 90.462% |
| BiOptic Inc. | 12.59 Million TWD | -219.774% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 104.264% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 139.676% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 124.378% |
| VBI | -25.31 Million TWD | 259.054% |
| CHO Pharma, Inc. | -203.79 Million TWD | 119.758% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 152.264% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 87.212% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 162.602% |
| NaviFUS Corp. | -123.12 Million TWD | 132.702% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 45.624% |
| Sinew Pharma Inc. | -160.34 Million TWD | 125.112% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 116.646% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 111.935% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 109.758% |
| AP Biosciences Inc | -196.52 Million TWD | 120.489% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 94.154% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 452.068% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 104.853% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 97.033% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 109.706% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 119.235% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 127.989% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 112.182% |
| TCI GENE Inc. | -689.25 Million TWD | 105.842% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 133.855% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 103.076% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -96.583% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 139.527% |
| PharmaEngine, Inc. | -860.8 Million TWD | 104.678% |
| Savior Lifetec Corporation | -812.54 Million TWD | 104.956% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 113.423% |
| OBI Pharma, Inc. | -398.22 Million TWD | 110.111% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 111.019% |
| Acepodia, Inc. | -6.02 Billion TWD | 100.669% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 101.184% |